Mark T. McLoughlin, Director at CYTOMEDIX INC (GTF), bought 13,334 shares at $0.75 ($10K) on 2008-09-05, disclosed to the SEC on 2008-09-09.
Open-market purchase of $10k GTF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.